Prestige Consumer Healthcare (PBH) Operating Expenses (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Operating Expenses of $74.9 million in Q4 2025, up 4.13% quarter-over-quarter from $71.9 million in Q3 2025, and up 8.38% on a YoY basis from $69.1 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Operating Expenses (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Operating Expenses history runs 16 years deep, the most recent figure standing at $74.9 million for Q4 2025.
- In Q4 2025, Operating Expenses rose 8.38% year-over-year to $74.9 million; the TTM figure through Dec 2025 stood at $296.9 million (up 3.91% YoY), while the FY2025 annual figure was $297.7 million, up 5.56% from the prior year.
- Operating Expenses was $74.9 million for Q4 2025 at Prestige Consumer Healthcare, up from $71.9 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $434.8 million in Q1 2023 to a low of $63.2 million in Q4 2022.
- Historically, Operating Expenses has averaged $90.0 million across 5 years, with a median of $71.8 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses jumped 508.59% in 2023, then slumped 83.98% in 2024.
- A 5-year view of Operating Expenses shows it stood at $72.5 million in 2021, then declined by 12.76% to $63.2 million in 2022, then grew by 12.48% to $71.1 million in 2023, then retreated by 2.84% to $69.1 million in 2024, then increased by 8.38% to $74.9 million in 2025.
- The last three Operating Expenses figures came in at $74.9 million (Q4 2025), $71.9 million (Q3 2025), and $68.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 475.11 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 96.91 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 74.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.88 Mn |
| Sep 30, 2025 | 71.91 Mn |
| Jun 30, 2025 | 68.58 Mn |
| Mar 31, 2025 | 81.58 Mn |
| Dec 31, 2024 | 69.09 Mn |
| Sep 30, 2024 | 73.04 Mn |
| Jun 30, 2024 | 73.98 Mn |
| Mar 31, 2024 | 69.66 Mn |
| Dec 31, 2023 | 71.11 Mn |
| Sep 30, 2023 | 71.77 Mn |
| Jun 30, 2023 | 69.48 Mn |
| Mar 31, 2023 | 434.76 Mn |
| Dec 31, 2022 | 63.22 Mn |
| Sep 30, 2022 | 76.63 Mn |
| Jun 30, 2022 | 73.11 Mn |
| Mar 31, 2022 | 71.44 Mn |
| Dec 31, 2021 | 72.47 Mn |
| Sep 30, 2021 | 79.15 Mn |
| Jun 30, 2021 | 67.67 Mn |
| Mar 31, 2021 | 66.12 Mn |